Science Corporation published preliminary data Tuesday from a late stage, multi-center clinical trial of a retina implant that showed promising results.
Using this prosthetic, scientists partially restored vision to people whose central visual field has holes or blurry spots. Trial participants could read text and recognize playing cards when using the implant, even though they were legally blind.
Ophthalmologist Frank Holz, the trial’s scientific coordinator, called the results a “milestone” in treating severe vision loss caused by age-related macular degeneration. “Prior to this, there have been no real treatment options to improve vision for these patients,” said Holz, a professor at University of Bonn, Germany.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
